View images of Zepbound and identify pills by imprint code, shape and color with the Drugs.com Pill Identifier.

The following 25 images provide visual information about the product associated with Zepbound NDC 0002-0152 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself.

Use Zepbound exactly as your healthcare provider says. Use Zepbound with a reduced-calorie diet and increased physical activity. Zepbound is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm. Use Zepbound 1 time each week, at any time of the day. Change (rotate) your injection site with each weekly injection.

This medication has been identified as Zepbound 7.5 mg/0.5 mL injection. It is supplied by Eli Lilly and Company. Zepbound is used in the treatment of Weight Loss (Obesity/Overweight); Obstructive Sleep Apnea/Hypopnea Syndrome and belongs to the drug class GLP-1 Agonists (Incretin Mimetics).

What does ZEPBOUND look like? View images of ZEPBOUND and identify pills by imprint, color or shape. If you need to save money on your ZEPBOUND, compare our prices.

ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.

Feb 3, 2025 · Zepbound (tirzepatide) is an FDA-approved medicine used for weight loss and weight management to help you lose weight and keep weight off, and it is also used for obstructive sleep apnea (OSA) with obesity.

Search from thousands of royalty-free Zepbound stock images and video for your next project. Download royalty-free stock photos, vectors, HD footage and more on Adobe Stock.

Jun 20, 2024 · ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.

ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.